secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENERON PHARMACEUTICALS, INC. (REGN)
CIK:        0000872589
Form:       8-K
Filed at:   2023-04-17T23:59:59+00:00
Accession:  0001104659-23-045897
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Regeneron Chair P. Roy Vagelos not to stand for re-election; Schleifer and Yancopoulos named Co-Chairs
--------------------------------------------------------------------------------

- Dr. Vagelos will not stand for re-election at June 9, 2023 Annual Meeting; will serve as Chair until then.
- Board plans to elect Leonard S. Schleifer, M.D., Ph.D. and George D. Yancopoulos, M.D., Ph.D. as Co-Chairs.
- Christine A. Poon will become Lead Independent Director effective after the Annual Meeting.
- Dr. Vagelos's decision not due to any disagreement with Regeneron.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/872589/000110465923045897/0001104659-23-045897-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/872589/000110465923045897/tm2312956d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-045897

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer